drugset / Trial / NCT03936621
Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers
Phase 2
Unknown
42 enrolled
British Columbia Cancer Agency
Lotte & John Hecht Memorial Foundation · collab
RandomizedCrossoverSingle-blindScreening
Summary
The study duration is 12 months. The initial enrollment visit will take approximately one hour. The Month 1, 3, 6, 7, 9 and 12 visits will take approximately 30 minutes each. The three telephone visits will take approximately 10 minutes each. The total time commitment to the study will be approximately four and a half hours.
Timeline
- Start
- 2019-06-01
- Primary completion
- 2021-06-01
- Completion
- 2022-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DOCONEXENT | Other / unclassified | 1.2 g | — |
| Comparator | Eicosapentaenoic acid | Small molecule | 2.4 g | — |